Patent 11186848 was granted and assigned to Regeneron Pharmaceuticals, Inc. on November, 2021 by the United States Patent and Trademark Office.
Disclosed herein are nucleic acids encoding for and proteins expressing chimeric C1q polypeptides, non-human animals comprising said nucleic acids, and methods of making or using said non-human animals.